New GN product to solve challenges for hearing aid users, says CEO

Resound Omnia will address hearing and speech understanding in noisy environments, a typical gripe among users, according to GN Hearing CEO Gitte Aabo.

Gitte Aabo, CEO of GN Hearing | Photo: GN Hearing / PR

GN Hearing’s new product, Resound Omnia, has been developed to tackle one of hearing aid users’ greatest challenges – noisy environments.

According to the hearing aid manufacturer’s chief executive, Gitte Aabo, the device will help solve this problem, which will increase satisfaction and reduce product return rates.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs